Phase II trial of triple-receptor tyrosine kinase receptor inhibitor nintedanib (BIBF 1120) in recurrent high-grade gliomas. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This ...
Looking for novel anticancer agents, researchers from Ho Chi Minh City University of Science (Vietnam) and colleagues recently identified KTt-45, a compound derived from 6-prenylnaringenin, as a ...
Researchers at Baylor College of Medicine have uncovered a previously unrecognized mechanism by which inherited calcium channel mutations disrupt early brain development and predispose children to ...
Towards the end of 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared on the scene, and practically shut down the world for the next several months. Since then, a slow and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results